The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.

Source:http://linkedlifedata.com/resource/pubmed/id/21321981

Prostate 2011 Sep 15 71 13 1455-65

Download in:

View as

Triples

General Info

PMID
21321981